Compare Rig Tenders Indonesia Tbk. (RIGS) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Rig Tenders Indonesia Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Rig Tenders Indonesia Tbk. trades at Rp705 (market cap 426.39B, 36.2K 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Rig Tenders Indonesia Tbk. is far larger — about 4.1× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| RIGS | SCPI | |
|---|---|---|
Market Cap | 426.39B | 104.4B |
Volume | 36.2K | — |
Lot | 362 | — |
Turnover | 25.16M | — |
Average Price | 695.12 | — |
Value | 25.16M | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Rig Tenders Indonesia Tbk.
PT Rig Tenders Indonesia Tbk (the Company) was established within the framework of the Foreign Capital Investment Law No. 1 year 1967, as amended by Law No. 11 year 1970, based on Notarial Deed of Mrs. Darwani Sidi Bakaroedin, S.H. No. 25 dated 22 January 1974, which was approved by the Minister of Justice of the Republic of Indonesia in his Decision Letter No. Y.A. 5/98/10, dated 1 April 1974, and was published in State Gazette of the Republic of Indonesia No. 39 dated 14 May 1974, Supplement No. 187/1974. PT. Rigs Tenders Indonesia provides shipping services for the offshore oil and gas industry in Indonesia waters. Supported by a fleet of 23 vessels since 1988.
Read more on RIGS →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
